Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Irritable Bowel Syndrome using Titrated Ondansetron Trial (TRITON)
2017-000533-31Phase 3Completed
- Sponsor
- Nottingham University Hospitals
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Diarrhea-predominant irritable bowel syndrome (IBS-D) comparing Ondansetron with Placebo (2 arms). Primary endpoint: FDA-recommended composite weekly responder endpoint. Started Jul 2017; status: completed.
02
Drugs
ondansetron
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on 2017-000533-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000533-31.